Webinar : 2022 ASH Update for Lymphoma & CLL Patients
Lymphoma and CLL Research Highlights from ASH 2022
Date and Time:
Tuesday, March 21st, 2023
4:00 pm EST
Each year, scientists and medical professionals from around the world gather together to share research and clinical updates in hematology at the American Society of Hematology (ASH) conference. ASH is the world’s largest professional society serving clinicians and scientists who are working to conquer blood diseases. At the conference, advancements in lymphoma and CLL treatments and care are presented, helping Canadian clinicians to understand and prepare for changes in treatment approaches as new therapies come to market.
At this patient-centered educational webinar, Dr. Banerji will provide an overview of research updates on the diagnosis and treatment of lymphoma including Non-Hodgkin’s Lymphomas (B-Cell and T-Cell), Hodgkin Lymphoma, and Chronic Lymphocytic Leukemia, based on the results presented at the ASH conference in December 2022.
Dr. Versha Banerji
Dr. Banerji is a Clinician Scientist at CancerCare Manitoba, a Senior Scientist at the Research Institute in Oncology and Hematology, and a co-investigator on the Research Manitoba CLL Research Cluster. Her main goals are bringing the most effective and safest therapies to patients by evaluating the role of metabolism in cancer using mitochondrial respiration as a biomarker for disease and response to therapy.